| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |